Preventive effect of Goshajinkigan on peripheral neurotoxicity of FOLFOX therapy (GENIUS trial): a placebo-controlled, double-blind, randomized phase III study

Verfasser / Beitragende:
[Eiji Oki, Yasunori Emi, Hiroshi Kojima, Jun Higashijima, Takeshi Kato, Yasuhiro Miyake, Masanori Kon, Yutaka Ogata, Kenichi Takahashi, Hideyuki Ishida, Hiroshi Saeki, Yoshihisa Sakaguchi, Takeharu Yamanaka, Toru Kono, Naohiro Tomita, Hideo Baba, Ken Shirabe, Yoshihiro Kakeji, Yoshihiko Maehara]
Ort, Verlag, Jahr:
2015
Enthalten in:
International Journal of Clinical Oncology, 20/4(2015-08-01), 767-775
Format:
Artikel (online)
ID: 605491194
LEADER caa a22 4500
001 605491194
003 CHVBK
005 20210128100508.0
007 cr unu---uuuuu
008 210128e20150801xx s 000 0 eng
024 7 0 |a 10.1007/s10147-015-0784-9  |2 doi 
035 |a (NATIONALLICENCE)springer-10.1007/s10147-015-0784-9 
245 0 0 |a Preventive effect of Goshajinkigan on peripheral neurotoxicity of FOLFOX therapy (GENIUS trial): a placebo-controlled, double-blind, randomized phase III study  |h [Elektronische Daten]  |c [Eiji Oki, Yasunori Emi, Hiroshi Kojima, Jun Higashijima, Takeshi Kato, Yasuhiro Miyake, Masanori Kon, Yutaka Ogata, Kenichi Takahashi, Hideyuki Ishida, Hiroshi Saeki, Yoshihisa Sakaguchi, Takeharu Yamanaka, Toru Kono, Naohiro Tomita, Hideo Baba, Ken Shirabe, Yoshihiro Kakeji, Yoshihiko Maehara] 
520 3 |a Background: Peripheral sensory neurotoxicity is a frequent adverse effect of oxaliplatin therapy. Calcium and magnesium (Ca/Mg) infusions are frequently used as preventatives, but a recent phase III trial failed to show that they prevent neurotoxicity. We therefore conducted a multicenter randomized phase III trial to compare fluorouracil, leucovorin, and oxaliplatin (mFOLFOX6) with and without Goshajinkigan (GJG), a traditional Japanese herbal medicine (Kampo), to determine GJG's potential for reducing peripheral neuropathy in patients with colorectal cancer. Methods: Patients with colon cancer who were undergoing adjuvant therapy with infusional mFOLFOX6 were randomly assigned to GJG (7.5mg three times daily) or placebo in a double-blind manner. The primary endpoint was the time to grade 2 or greater neuropathy, which was determined at any point during or after oxaliplatin-based therapy using version 3 of the National Cancer Institute Common Terminology Criteria for Adverse Events (NCI CTCAE). Findings: An interim analysis was performed when 142 of the planned 310 patients had been enrolled and the safety assessment committee recommended that the study be discontinued. One hundred eighty-two patients were evaluable for response. They included 89 patients in the GJG group and 93 patients in the placebo group. The incidence of grade 2 or greater neurotoxicity was 50.6% in the GJG group and 31.2% in the placebo group. A Cox proportional hazards analysis indicated that the use of GJG was significantly associated with the incidence of neuropathy (hazard ratio, 1.908; p=0.007). Conclusion: Goshajinkigan did not prevent oxaliplatin-associated peripheral neuropathy in this clinical trial. The clinical study was therefore terminated. 
540 |a Japan Society of Clinical Oncology, 2015 
690 7 |a Adjuvant chemotherapy  |2 nationallicence 
690 7 |a Colon cancer  |2 nationallicence 
690 7 |a Colorectal cancer  |2 nationallicence 
690 7 |a Goshajinkigan  |2 nationallicence 
690 7 |a Herbal medicine, Kampo  |2 nationallicence 
690 7 |a Peripheral neuropathy  |2 nationallicence 
700 1 |a Oki  |D Eiji  |u Department of Surgery and Science, Graduate School of Medical Science, Kyushu University, Fukuoka, Japan  |4 aut 
700 1 |a Emi  |D Yasunori  |u Department of Surgery, Saiseikai Fukuoka General Hospital, Fukuoka, Japan  |4 aut 
700 1 |a Kojima  |D Hiroshi  |u Department of Gastroenterological Surgery, Aichi Cancer Center Aichi Hospital, Nagoya, Japan  |4 aut 
700 1 |a Higashijima  |D Jun  |u Department of Digestive and Pediatric Surgery, Faculty of Medicine, University of Tokushima, Tokushima, Japan  |4 aut 
700 1 |a Kato  |D Takeshi  |u Department of Surgery, Kansai Rosai Hospital, Amagasaki, Japan  |4 aut 
700 1 |a Miyake  |D Yasuhiro  |u Department of Surgery, Minoh City Hospital, Minoh, Japan  |4 aut 
700 1 |a Kon  |D Masanori  |u Department of Surgery, Kansai Medical University, Osaka, Japan  |4 aut 
700 1 |a Ogata  |D Yutaka  |u Department of Surgery, Kurume University Medical Center, Kurume, Japan  |4 aut 
700 1 |a Takahashi  |D Kenichi  |u Department of Surgery, Aomori Prefectural Central Hospital, Aomori, Japan  |4 aut 
700 1 |a Ishida  |D Hideyuki  |u Department of Digestive Tract and General Surgery, Saitama Medical Center, Saitama Medical School, Saitama, Japan  |4 aut 
700 1 |a Saeki  |D Hiroshi  |u Department of Surgery and Science, Graduate School of Medical Science, Kyushu University, Fukuoka, Japan  |4 aut 
700 1 |a Sakaguchi  |D Yoshihisa  |u Department of Gastroenterological Surgery, Kyushu National Medical Center, Fukuoka, Japan  |4 aut 
700 1 |a Yamanaka  |D Takeharu  |u Department of Biostatistics, Yokohama City University, Yokohama, Japan  |4 aut 
700 1 |a Kono  |D Toru  |u Sapporo Higashi Tokushukai Hospital, Sapporo, Japan  |4 aut 
700 1 |a Tomita  |D Naohiro  |u Department of Surgery, Hyogo College of Medicine, Nishinomiya, Japan  |4 aut 
700 1 |a Baba  |D Hideo  |u Department of Gastroenterological Surgery, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan  |4 aut 
700 1 |a Shirabe  |D Ken  |u Department of Surgery and Science, Graduate School of Medical Science, Kyushu University, Fukuoka, Japan  |4 aut 
700 1 |a Kakeji  |D Yoshihiro  |u Department of Gastrointestinal Surgery, Kobe University, Kobe, Japan  |4 aut 
700 1 |a Maehara  |D Yoshihiko  |u Department of Surgery and Science, Graduate School of Medical Science, Kyushu University, Fukuoka, Japan  |4 aut 
773 0 |t International Journal of Clinical Oncology  |d Springer Japan  |g 20/4(2015-08-01), 767-775  |x 1341-9625  |q 20:4<767  |1 2015  |2 20  |o 10147 
856 4 0 |u https://doi.org/10.1007/s10147-015-0784-9  |q text/html  |z Onlinezugriff via DOI 
898 |a BK010053  |b XK010053  |c XK010000 
900 7 |a Metadata rights reserved  |b Springer special CC-BY-NC licence  |2 nationallicence 
908 |D 1  |a research-article  |2 jats 
949 |B NATIONALLICENCE  |F NATIONALLICENCE  |b NL-springer 
950 |B NATIONALLICENCE  |P 856  |E 40  |u https://doi.org/10.1007/s10147-015-0784-9  |q text/html  |z Onlinezugriff via DOI 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Oki  |D Eiji  |u Department of Surgery and Science, Graduate School of Medical Science, Kyushu University, Fukuoka, Japan  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Emi  |D Yasunori  |u Department of Surgery, Saiseikai Fukuoka General Hospital, Fukuoka, Japan  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Kojima  |D Hiroshi  |u Department of Gastroenterological Surgery, Aichi Cancer Center Aichi Hospital, Nagoya, Japan  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Higashijima  |D Jun  |u Department of Digestive and Pediatric Surgery, Faculty of Medicine, University of Tokushima, Tokushima, Japan  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Kato  |D Takeshi  |u Department of Surgery, Kansai Rosai Hospital, Amagasaki, Japan  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Miyake  |D Yasuhiro  |u Department of Surgery, Minoh City Hospital, Minoh, Japan  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Kon  |D Masanori  |u Department of Surgery, Kansai Medical University, Osaka, Japan  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Ogata  |D Yutaka  |u Department of Surgery, Kurume University Medical Center, Kurume, Japan  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Takahashi  |D Kenichi  |u Department of Surgery, Aomori Prefectural Central Hospital, Aomori, Japan  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Ishida  |D Hideyuki  |u Department of Digestive Tract and General Surgery, Saitama Medical Center, Saitama Medical School, Saitama, Japan  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Saeki  |D Hiroshi  |u Department of Surgery and Science, Graduate School of Medical Science, Kyushu University, Fukuoka, Japan  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Sakaguchi  |D Yoshihisa  |u Department of Gastroenterological Surgery, Kyushu National Medical Center, Fukuoka, Japan  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Yamanaka  |D Takeharu  |u Department of Biostatistics, Yokohama City University, Yokohama, Japan  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Kono  |D Toru  |u Sapporo Higashi Tokushukai Hospital, Sapporo, Japan  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Tomita  |D Naohiro  |u Department of Surgery, Hyogo College of Medicine, Nishinomiya, Japan  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Baba  |D Hideo  |u Department of Gastroenterological Surgery, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Shirabe  |D Ken  |u Department of Surgery and Science, Graduate School of Medical Science, Kyushu University, Fukuoka, Japan  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Kakeji  |D Yoshihiro  |u Department of Gastrointestinal Surgery, Kobe University, Kobe, Japan  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Maehara  |D Yoshihiko  |u Department of Surgery and Science, Graduate School of Medical Science, Kyushu University, Fukuoka, Japan  |4 aut 
950 |B NATIONALLICENCE  |P 773  |E 0-  |t International Journal of Clinical Oncology  |d Springer Japan  |g 20/4(2015-08-01), 767-775  |x 1341-9625  |q 20:4<767  |1 2015  |2 20  |o 10147